Fate Therapeutics Inc (NASDAQ:FATE)
| 19.15 Delayed Data As of Dec 08 |  +0.04 / +0.21%Today’s Change | 17.10 Today|||52-Week Range 66.56 | -67.27% Year-to-Date |
Latest FATE News | Press Releases
No recent news for Fate Therapeutics Inc.
Today’s Trading
| Previous close | 19.11 |
| Today’s open | 19.20 |
| Day’s range | 18.57 - 19.32 |
| Volume | 103,470 |
| Average volume (3 months) | 1,334,669 |
| Market cap | $2.0B |
Data as of 3:21pm ET, 12/08/2022
Growth & Valuation
| Earnings growth (last year) | -6.39% |
| Earnings growth (this year) | -43.95% |
| Earnings growth (next 5 years) | -37.40% |
| Revenue growth (last year) | +77.66% |
| P/E ratio | NM |
| Price/Sales | 99.27 |
| Price/Book | 2.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XNCRXencor Inc | +0.36 | +1.21% |
| ---- | ||
| BCRXBioCryst Pharmaceuti... | -0.16 | -1.50% |
| ARVNArvinas Inc | +0.51 | +1.38% |
Data as of 3:22pm ET, 12/08/2022
Financials
| Next reporting date | February 27, 2023 |
| EPS forecast (this quarter) | -$0.88 |
| Annual revenue (last year) | $55.8M |
| Annual profit (last year) | -$212.2M |
| Net profit margin | -379.89% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
